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Reasons for poor outcome after valve replacement for 
mitral regurgitation. Currently, correction of mitral regurgi- 
tation has a higher operative mortality and a worse outcome 
than surgery for other valve lesions of the left side of the 
heart. Recent statistics indicate a survival rate of only 50% at 
10 years after mitral valve replacement for mitral regurgita- 
tion (1,2). This is in sharp contrast to the results for 
correction of the other left-sided regurgitant lesion, aortic 
regurgitation, in which operative mortality has decreased 
from 11% in the 1960s and early 1970s to 6% in recent years, 
and 10 year survival rate approaches 80% (3,4). Correction 
of mitral regurgitation is attended by a poor outcome for 
several reasons: 1) concealed preoperative left ventricular 
dysfunction predisposes the patient to poor postoperative 
ventricular function; 2) creation of unfavorable preoperative 
geometry aggravates the potential for reduced postoperative 
ventricular performance; 3) frequent coexistence of coro- 
nary artery disease as a cause of mitral regurgitation in- 
creases the risk of an intraoperative or subsequent myocar- 
dial infarction; and 4) severance of chordae tendineae during 
mitral valve replacement has an adverse effect on ventricular 
function. 
Concealed left ventricular dysfunction. Mitral regurgita- 
tion affords an additional low pressure pathway for ejection 
of blood from the left ventricle. This pathway acts to reduce 
overall resistance to ejection, thereby reducing left ventric- 
ular afterload, while the volume overload resulting from the 
lesion increases preload. Reduced afterload and increased 
preload in mitral regurgitation augment ejection perfor- 
mance. Although much has been written about the need for 
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a load-independent tool to assess clinical left ventricular 
function, load-dependent indexes of ejection performance 
are still by far the most commonly used tools to evaluate 
contractile function. In mitral regurgitation the favorable 
loading conditions cause these indexes to overestimate ven- 
tricular function. In this regard, ejection fraction in the range 
of 0.55 to 0.60 or echocardiographic shortening fraction in 
the range of 0.25 to 0.30 is frequently coexistent with 
significant muscle dysfunction (5,6). 
Unfavorable preoperative geometry and its effect on post- 
operative loading conditions. The left ventricle in mitral 
regurgitation dilates with little increase in wall thickness, 
resulting in a high left ventricular radius (r) to thickness (h) 
ration (r/h) (7). Afterload estimated by wall stress is derived 
from the Laplace relation, where wall stress = (pressure x r) 
+ 2h. Thus, as r/h increases, stress increases, increasing 
afterload despite the unloading effect of the lesion itself. 
Wall stress is typically normal (rather than subnormal) in 
compensated mitral regurgitation and actually higher than 
normal in decompensated mitral regurgitation (8). In this 
setting of normal or increased afterload, mitral valve re- 
placement or repair, which closes off the low impedance 
pathway into the left atrium, results in an immediate further 
increase in afterload (9). This increase in postoperative 
afterload together with decreased preload (as the volume 
overload is removed) invariably causes a decrease in ejec- 
tion performance (6,lO). If some contractile reserve remains, 
the ventricle may be able to compensate for the imposition of 
these unfavorable loading conditions; in this case, the de- 
crease in ejection performance is only mild. If all contractile 
reserve has been exhausted, the unfavorable loading candi- 
tions imposed by mitral valve replacement cause a precipi- 
tous, uncompensated decrease in ejection performance, 
which persists for years after mitral valve replacement (11). 
Coronary artery disease. Mitral regurgitation is the only 
left-sided valve lesion that can have coronary artery disease 
as its primary etiology. An estimated 25% of patients under- 
going mitral valve repair or replacement have coronary 
disease as the primary etiologic factor (12,13). If the mitral 
regurgitation is coincidentally present with myocardial inf- 
arction or if myocardial infarction develops consequent to 
the coronary disease, ventricular function will be worse than 
that created by the valve lesion itself. 
Interaction of the valve apparatus in the ventricle: impact 
of the current study. Early studies by Rushmer et al. (14) 
and Lillihei et al. (15) demonstrated that the mitral valve 
apparatus and its attachments to the papillary muscles do 
more than prevent systolic mitral regurgitation. These at- 
tachments enhance long-axis contraction, “priming” the 
short axis of the left ventricle for its major role in ventricular 
ejection by causing a shape change toward spherical in early 
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systole. Thus, the interaction of the mitral valve with the 
papillary muscles enhances left ventricular performance. 
The current study in the Journal by Pitarys et al. (16) 
demonstrates the results of chordal severance on regional 
myocardial function. Radial shortening in the region of the 
insertion of the posteromedial papillary muscle decreased 
sharply after mitral valve replacement with chordal resec- 
tion. Although this decrease did not produce a statistically 
significant decrease in global ventricular ejection perfor- 
mance, there was a correlation between postoperative ejec- 
tion performance and regional dysfunction. Because consid- 
erable data indicate that global ejection fraction usually 
decreases after mitral valve replacement (6,10,1 l), it is likely 
that the relatively small sample size of the current study (16) 
is the source of its inability to detect such a decrease. The 
importance of the current study is not that it failed to detect 
this decrease, but rather that the regional dysfunction it 
demonstrated helps to explain why other studies did find a 
significant decline in ejection performance after mitral valve 
replacement. 
This clinical study (16) adds to previous experimental 
work (17), demonstrating a reduction in chamber elastance 
caused by the severance of the chordae tendineae. Con- 
versely, clinical studies (1819) demonstrate that preserva- 
tion of the chordae tendineae helps maintain ventricular 
performance. The difference in ventricular performance be- 
tween operations in which the chordae tendineae were 
preserved versus severed can probably be explained; 
whereas unfavorable postoperative loading conditions are 
imposed in both valve repair and valve replacement, replace- 
ment with chordal severance further impairs the ventricle’s 
ability to overcome these unfavorable loading conditions and 
this results in reduced ejection performance. It is most likely 
the preservation of ventricular function combined with the 
obvious advantage of avoiding implantation of a prosthetic 
valve that explains valve repair has a substantially better 
result than does replacement (2,18-21). 
Conclusions. With knowledge gained about the interac- 
tion between the left ventricle in mitral regurgitation and the 
mitral valve apparatus, it is reasonable to expect that mor- 
tality can be reduced and long-term outcome for patients 
with mitral regurgitation improved in the 1990s. As cardiol- 
ogists recognize the concealed left ventricular dysfunction in 
this disease and as surgeons improve the art of valve repair, 
better candidates for surgery will undergo a better operation. 
Even for those patients who have neglected their disease 
until ventricular dysfunction is advanced, repair may offer a 
reasonable outcome by helping to preserve function without 
causing further depression. 
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